MedPath

Resilience impact on diabetic patients

Phase 2
Conditions
Type II diabetes.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2016022726790N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Diagnosis of type II diabetes by an endocrinologist, aged 30 to 80 years, resiliency score less than 52, the middle and lower self-efficacy, residing in Shiraz. Exclusion criteria: Presence of mental disorders and mental retardation, lack of participation in more than two sessions, attend the same classes Educational

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Self- efficacy. Timepoint: Before intervention, immediately after the intervention, one month after the intervention. Method of measurement: Diabetes Management Self- efficacy Scale.
Secondary Outcome Measures
NameTimeMethod
Resilience. Timepoint: Before intervention, immediately after the intervention, one month after the intervention. Method of measurement: Conner- Davidson Resilience scale.
© Copyright 2025. All Rights Reserved by MedPath